Fish Oil Improves Pathway-Oriented Profiling of Lipid Mediators for Maintaining Metabolic Homeostasis in Adipose Tissue of Prediabetic Rats.
adipose tissue
inflammation
prediabetes
specialized resolvers
ω3 lipid mediators
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
09
2020
accepted:
31
03
2021
entrez:
10
5
2021
pubmed:
11
5
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Adipose tissue is now recognized as an active organ with an important homeostatic function in glucose and lipid metabolism and the development of insulin resistance. The present research investigates the role of lipid mediators and lipid profiling for controlling inflammation and the metabolic normal function of white adipose tissue from rats suffering from diet-induced prediabetes. Additionally, the contribution to the adipose lipidome induced by the consumption of marine ω-3 PUFAs as potential regulators of inflammation is addressed. For that, the effects on the inflammatory response triggered by high-fat high-sucrose (HFHS) diets were studied in male Sprague-Dawley rats. Using SPE-LC-MS/MS-based metabolo-lipidomics, a range of eicosanoids, docosanoids and specialized pro-resolving mediators (SPMs) were measured in white adipose tissue. The inflammatory response occurring in prediabetic adipose tissue was associated with the decomposition of ARA epoxides to ARA-dihydroxides, the reduction of oxo-derivatives and the formation of prostaglandins (PGs). In an attempt to control the inflammatory response initiated, LOX and non-enzymatic oxidation shifted toward the production of the less pro-inflammatory EPA and DHA metabolites rather than the high pro-inflammatory ARA hydroxides. Additionally, the change in LOX activity induced the production of intermediate hydroxides precursors of SPMs as protectins (PDs), resolvins (Rvs) and maresins (MaRs). This compensatory mechanism to achieve the restoration of tissue homeostasis was significantly strengthened through supplementation with fish oils. Increasing proportions of ω-3 PUFAs in adipose tissue significantly stimulated the formation of DHA-epoxides by cytochrome P450, the production of non-enzymatic EPA-metabolites and prompted the activity of 12LOX. Finally, protectin PDX was significantly reduced in the adipose tissue of prediabetic rats and highly enhanced through ω-3 PUFAs supplementation. Taken together, these actively coordinated modifications constitute key mechanisms to restore adipose tissue homeostasis with an important role of lipid mediators. This compensatory mechanism is reinforced through the supplementation of the diet with fish oils with high and balanced contents of EPA and DHA. The study highlights new insides on the targets for effective treatment of incipient diet-induced diabetes and the mechanism underlying the potential anti-inflammatory action of marine lipids.
Identifiants
pubmed: 33968013
doi: 10.3389/fimmu.2021.608875
pmc: PMC8097180
doi:
Substances chimiques
Biomarkers
0
Fish Oils
0
Inflammation Mediators
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
608875Informations de copyright
Copyright © 2021 Dasilva, Lois, Méndez, Miralles-Pérez, Romeu, Ramos-Romero, Torres and Medina.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AG-I declared a shared affiliation with several of the authors (IM, GD, LM, JT and SR) to the handling editor at the time of the review.
Références
Nat Rev Endocrinol. 2017 Nov;13(11):633-643
pubmed: 28799554
Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E381-7
pubmed: 15494611
Anal Biochem. 2001 May 15;292(2):234-44
pubmed: 11355856
J Intern Med. 2007 Oct;262(4):408-14
pubmed: 17875176
Mol Nutr Food Res. 2020 Feb;64(4):e1900824
pubmed: 31797565
Nutrients. 2019 Oct 31;11(11):
pubmed: 31683529
Cell Metab. 2014 Jan 7;19(1):21-36
pubmed: 24239568
Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:84-92
pubmed: 22951339
FASEB J. 2007 Feb;21(2):325-32
pubmed: 17267386
J Nutr Biochem. 2017 Oct;48:29-35
pubmed: 28672272
Curr Hypertens Rep. 2010 Apr;12(2):99-104
pubmed: 20424938
Diabetes. 2016 May;65(5):1245-54
pubmed: 26884438
Adv Nutr. 2011 Jan;2(1):15-22
pubmed: 22211186
J Lipid Res. 1986 Jan;27(1):114-20
pubmed: 3958609
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):536-41
pubmed: 25550510
Mol Nutr Food Res. 2018 Aug;62(16):e1800373
pubmed: 29979820
Am J Physiol Cell Physiol. 2017 Sep 1;313(3):C295-C304
pubmed: 28659287
Obesity (Silver Spring). 2013 Mar;21(3):E294-302
pubmed: 23404690
J Cardiovasc Pharmacol. 2013 Sep;62(3):285-97
pubmed: 23676336
Molecules. 2019 Jun 19;24(12):
pubmed: 31248084
Prostaglandins Other Lipid Mediat. 2019 Feb;140:31-39
pubmed: 30593866
FEBS J. 2010 Mar;277(6):1410-9
pubmed: 20136655
Sci Rep. 2019 Nov 12;9(1):16628
pubmed: 31719544
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E543-E551
pubmed: 29584445
Food Chem. 2016 Aug 15;205:196-203
pubmed: 27006231
Clin Chem. 1993 May;39(5):825-32
pubmed: 8485873
Am J Pathol. 2010 Oct;177(4):1576-91
pubmed: 20813960
J Nutr Biochem. 2017 May;43:53-67
pubmed: 28260647
Int Immunopharmacol. 2012 Jun;13(2):204-14
pubmed: 22498761
J Endocr Soc. 2018 Dec 24;3(3):504-515
pubmed: 30788452
J Clin Med. 2015 Dec 31;5(1):
pubmed: 26729182
Mar Drugs. 2018 Sep 26;16(10):
pubmed: 30261666
Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1137-54
pubmed: 23047497
Int J Obes (Lond). 2015 Jul;39(7):1151-60
pubmed: 25801691
J Thromb Haemost. 2005 Sep;3(9):1962-75
pubmed: 16102103
Anal Bioanal Chem. 2014 May;406(12):2827-39
pubmed: 24618987
Annu Rev Pharmacol Toxicol. 2013;53:37-58
pubmed: 23020295
J Lipid Res. 2014 Jun;55(6):1150-64
pubmed: 24634501
J Immunol. 2010 Apr 1;184(7):3978-87
pubmed: 20207999
Biochem Biophys Res Commun. 2005 Sep 9;334(4):987-95
pubmed: 16039985
Crit Rev Immunol. 2018;38(5):343-365
pubmed: 30806214
Br J Nutr. 2013 Sep 14;110(5):871-9
pubmed: 23414551
Acta Physiol Scand. 2005 Aug;184(4):285-93
pubmed: 16026420
J Immunol. 2012 Sep 1;189(5):2597-605
pubmed: 22844113
Genome Biol. 2007;8(3):R38
pubmed: 17355638
Cell Metab. 2005 Oct;2(4):251-61
pubmed: 16213227
J Nutr Biochem. 2016 Apr;30:126-32
pubmed: 27012629
Sci Rep. 2017 May 3;7(1):1397
pubmed: 28469249
Am J Clin Nutr. 2011 Jan;93(1):186-91
pubmed: 21084651
J Lipid Res. 2016 Apr;57(4):663-73
pubmed: 26912395
Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39
pubmed: 19723556
FASEB J. 2011 Jul;25(7):2399-407
pubmed: 21478260
Am J Transl Res. 2010 Jul 22;2(4):447-57
pubmed: 20733953
Mol Cell Endocrinol. 2016 Jan 5;419:44-59
pubmed: 26433072
Lipids Health Dis. 2009 Aug 27;8:37
pubmed: 19712485
J Clin Invest. 1979 Aug;64(2):534-40
pubmed: 222812